3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
18
Phase 1
7
Phase 3
6
Phase 1/2
5
Phase NA
2
Phase EARLY_PHASE1
1
Phase 4
1
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
2
NET
1
Conditions
Neuroendocrine Tumors
1
Interventions
Everolimus
2
lutetium Lu 177 dotatate
1
Somatostatin
1
Sirolimus
1
Positron Emission Tomography Computed Tomography
1
Oxaliplatin
1
Leucovorin
1
Injections
1
Fluorouracil
1
Bevacizumab
1
Axitinib
1
Al18F-NOTA-octreotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
lutetium Lu 177 dotatate
×
NET
×
Clear all
NCT03590119
2022-11-08
LUTIA
UMC Utrecht
Phase 2/3
Completed
26 enrolled